Neuroleptic malignant syndrome following quetiapine treatment in a patient with dementia with Lewy bodies

Asian J Psychiatr. 2017 Dec:30:173-174. doi: 10.1016/j.ajp.2017.10.018. Epub 2017 Oct 23.

Authors

Ryota Kobayashi¹, Yoshihiko Matsumoto², Hiroshi Hayashi², Akihito Suzuki², Koichi Otani²

Affiliations

¹ Department of Psychiatry, Yamagata University School of Medicine, 2-2-2 Iidanishi, Yamagata 990-9585, Japan. Electronic address: ryo.kobayashi@med.id.yamagata-u.ac.jp.
² Department of Psychiatry, Yamagata University School of Medicine, 2-2-2 Iidanishi, Yamagata 990-9585, Japan.

PMID: 29080512
DOI: 10.1016/j.ajp.2017.10.018

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Aged
Antipsychotic Agents / adverse effects*
Antipsychotic Agents / therapeutic use
Humans
Lewy Body Disease / drug therapy*
Male
Neuroleptic Malignant Syndrome / etiology*
Quetiapine Fumarate / adverse effects*
Quetiapine Fumarate / therapeutic use

Substances

Antipsychotic Agents
Quetiapine Fumarate